- Home
- CPOP vs IMUX Comparison
CPOP vs IMUX Comparison
Compare CPOP & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPOP
- IMUX
- Stock Information
- Founded
- CPOP 2007
- IMUX 2016
- Country
- CPOP China
- IMUX United States
- Employees
- CPOP N/A
- IMUX N/A
- Industry
- CPOP Services-Misc. Amusement & Recreation
- IMUX Biotechnology: Pharmaceutical Preparations
- Sector
- CPOP Consumer Discretionary
- IMUX Health Care
- Exchange
- CPOP Nasdaq
- IMUX Nasdaq
- Market Cap
- CPOP 98.5M
- IMUX 90.4M
- IPO Year
- CPOP 2021
- IMUX N/A
- Fundamental
- Price
- CPOP $1.64
- IMUX $0.79
- Analyst Decision
- CPOP
- IMUX Strong Buy
- Analyst Count
- CPOP 0
- IMUX 5
- Target Price
- CPOP N/A
- IMUX $7.50
- AVG Volume (30 Days)
- CPOP 1.3M
- IMUX 1.3M
- Earning Date
- CPOP 10-28-2025
- IMUX 11-06-2025
- Dividend Yield
- CPOP N/A
- IMUX N/A
- EPS Growth
- CPOP N/A
- IMUX N/A
- EPS
- CPOP N/A
- IMUX N/A
- Revenue
- CPOP $65,186,721.00
- IMUX N/A
- Revenue This Year
- CPOP N/A
- IMUX N/A
- Revenue Next Year
- CPOP N/A
- IMUX N/A
- P/E Ratio
- CPOP N/A
- IMUX N/A
- Revenue Growth
- CPOP 108.29
- IMUX N/A
- 52 Week Low
- CPOP $0.46
- IMUX $0.56
- 52 Week High
- CPOP $2.47
- IMUX $2.11
- Technical
- Relative Strength Index (RSI)
- CPOP 73.15
- IMUX 41.67
- Support Level
- CPOP $1.15
- IMUX $0.74
- Resistance Level
- CPOP $2.13
- IMUX $0.90
- Average True Range (ATR)
- CPOP 0.19
- IMUX 0.06
- MACD
- CPOP 0.04
- IMUX -0.00
- Stochastic Oscillator
- CPOP 51.96
- IMUX 23.12
About CPOP Pop Culture Group Co. Ltd
Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.